Osmotica Pharmaceuticals plc to Present at Jefferies Virtual Optical Health Summit
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) announced that CEO Brian Markison and COO James Schaub will present at the Jefferies Virtual Optical Health Summit on June 17, 2020, at 2:30 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) announced that CEO Brian Markison and COO James Schaub will present at the Jefferies Virtual Optical Health Summit on June 17, 2020, at 2:30 p.m. Eastern Time. The presentation will be available via live webcast and can be accessed on the Company's website, where it will be archived for 30 days. Osmotica focuses on developing specialty biopharmaceuticals targeting underserved patient populations and has operations in the U.S., Argentina, and Hungary.
Details
News Market Reaction – OSMT
The recorded move for OSMT in the trading session of this news was +10.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BRIDGEWATER, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and James “JD” Schaub, Chief Operating Officer, will present at the Jefferies Virtual Optical Health Summit as follows:
| Date: | Wednesday, June 17, 2020 |
| Time: | 2:30 p.m. Eastern Time |
| Webcast: | http://wsw.com/webcast/jeff131/osmt/ |
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.osmotica.com under the “Investor & News” section.
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.
Osmotica has operations in the United States, Argentina, and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.